DexCom, Inc. (NASDAQ:DXCM) announced today results from the CONNECT randomized controlled trial, demonstrating the use of ...
Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in ...
Researchers shared findings today at the American Diabetes Association Scientific Sessions (ADA 2026) in New Orleans. San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results